Offer - Urjas Oil for just ₹ 1 X
Labetol Injection is a prescription drug, available for use as Injection. It is typically used for the treatment of High BP. Other than this, Labetol Injection has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Labetol Injection is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Labetol Injection can also lead to other problems, which have been listed below. Normally, these side effects of Labetol Injection are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Labetol Injection's effect during pregnancy is Severe and Mild while nursing. In addition, Labetol Injection's effects on the liver, heart and kidney are discussed below in the Labetol Injection related warnings section.
Labetol Injection is contraindicated in people with pre-existing medical conditions like Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease) as it can result in adverse effects. Some other conditions that can be affected by Labetol Injection are listed in the contraindications section below.
Besides this, Labetol Injection may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Labetol Injection is considered not safe while driving, and is not addictive.
Labetol Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Geriatric |
|
Adult |
|
Is the use of Labetol Injection safe for pregnant women?
Labetol can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Labetol Injection safe during breastfeeding?
Breastfeeding women can take Labetol as it bears very minor side effects for them.
What is the effect of Labetol Injection on the Kidneys?
There are no side effects of Labetol on the kidneys.
What is the effect of Labetol Injection on the Liver?
Side effects of Labetol rarely affect the liver.
What is the effect of Labetol Injection on the Heart?
Labetol has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Labetol Injection unless your doctor advises you to do so -
Is this Labetol Injection habit forming or addictive?
Labetol Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Labetol Injection can make you feel drowsy.
Is it safe?
Labetol Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Labetol Injection cannot treat any kind of mental disorder.
Interaction between Food and Labetol Injection
Labetol Injection may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Labetol Injection
Consumption of alcohol and Labetol Injection together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Trandate® (labetalol hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 735-737